Cargando…

Malignant Peritoneal Mesothelioma: Patterns of Care and Survival in the Netherlands: A Population-Based Study

BACKGROUND: Malignant peritoneal mesothelioma (MPM) is a rare and aggressive disease. Recently, focus has shifted toward a more aggressive and multimodal treatment approach. This study aimed to assess the patterns of care and survival for MPM patients in the Netherlands on a nationwide basis. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Boer, Nadine L., van Kooten, Job P., Damhuis, Ronald A. M., Aerts, Joachim G. J. V., Verhoef, Cornelis, Madsen, Eva V. E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2019
Materias:	Health Services Research and Global Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6864027/ https://www.ncbi.nlm.nih.gov/pubmed/31620941 http://dx.doi.org/10.1245/s10434-019-07803-z

Ejemplares similares

Adjuvant dendritic cell based immunotherapy (DCBI) after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal mesothelioma, a phase II single centre open-label clinical trial: rationale and design of the MESOPEC trial
por: de Boer, Nadine L, et al.
Publicado: (2019)

Incidence, treatment and survival of malignant pleural and peritoneal mesothelioma: a population-based study
por: van Kooten, Job P, et al.
Publicado: (2022)

Adjuvant dendritic cell-based immunotherapy after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with malignant peritoneal mesothelioma: a phase II clinical trial
por: Dietz, Michelle V, et al.
Publicado: (2023)

Intraperitoneal paclitaxel for patients with primary malignant peritoneal mesothelioma: a phase I/II dose escalation and safety study—INTERACT MESO
por: van Kooten, Job P, et al.
Publicado: (2022)

Emerging Treatments for Malignant Pleural Mesothelioma: Where Are We Heading?
por: Cantini, Luca, et al.
Publicado: (2020)

Cellular Immunotherapy and Locoregional Administration of CAR T-Cells in Malignant Pleural Mesothelioma
por: Belderbos, Robert A., et al.
Publicado: (2020)

Molecular alterations and potential actionable mutations in peritoneal mesothelioma: a scoping review of high-throughput sequencing studies
por: Dietz, M.V., et al.
Publicado: (2023)

Lurbinectedin in Refractory Diffuse Malignant Peritoneal Mesothelioma: Report of Two Cases
por: Gros, Louis, et al.
Publicado: (2021)

Surgical Treatment of Malignant Peritoneal Mesothelioma: Past, Present, and Future
por: Alexander, H. Richard
Publicado: (2009)

Apatinib Mesylate Inhibits the Proliferation and Metastasis of Epithelioid Malignant Peritoneal Mesothelioma In Vitro and In Vivo
por: Yang, Zhi-Ran, et al.
Publicado: (2020)

Association Between Waiting Time from Diagnosis to Treatment and Survival in Patients with Curable Gastric Cancer: A Population-Based Study in the Netherlands
por: Brenkman, H. J. F., et al.
Publicado: (2017)

Malignant Peritoneal Mesothelioma
por: Fukunaga, Tomohiko, et al.
Publicado: (2022)

Peritoneal Malignant Psammomatous Mesothelioma
por: Pusiol, Teresa, et al.
Publicado: (2010)

Preclinical Models of Malignant Mesothelioma
por: Testa, Joseph R., et al.
Publicado: (2020)

Immunotherapy in Malignant Pleural Mesothelioma
por: de Gooijer, Cornedine J., et al.
Publicado: (2020)

Efficacy and Adverse Events of Apatinib Salvage Treatment for Refractory Diffuse Malignant Peritoneal Mesothelioma: A Pilot Study
por: Yang, Zhi-Ran, et al.
Publicado: (2022)

Chemotherapy After Diagnosis of Malignant Bowel Obstruction is Associated with Superior Survival for Medicare Patients with Advanced Malignancy
por: Bateni, Sarah B., et al.
Publicado: (2021)

Molecular Pathways in Peritoneal Mesothelioma: A Minireview of New Insights
por: Fortarezza, Francesco, et al.
Publicado: (2022)

Survival Outcomes After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy in Patients with Synchronous Versus Metachronous Onset of Peritoneal Metastases of Colorectal Carcinoma
por: Dietz, Michelle V., et al.
Publicado: (2022)

Editorial: Emerging Therapies for Malignant Mesothelioma
por: van Zandwijk, Nico, et al.
Publicado: (2020)

Predictive Ability of C-Reactive Protein in Detecting Short-Term Complications After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Retrospective Cross-Sectional Study
por: van Kooten, Job P., et al.
Publicado: (2020)

Nasogastric- vs. percutaneous gastrostomy tube for prophylactic gastric decompression after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy
por: van Kooten, Job P., et al.
Publicado: (2021)

Treatment of Patients with Malignant Peritoneal Mesothelioma
por: Li, Claire Y., et al.
Publicado: (2022)

Locally Recurrent Rectal Cancer: Toward a Second Chance at Cure? A Population-Based, Retrospective Cohort Study
por: Swartjes, Hidde, et al.
Publicado: (2023)

Challenging Diagnostic Process for a Malignant Peritoneal Mesothelioma Patient With Ascites and Pleural Effusion: A Case Report and Review of the Literature
por: Zeng, Xiaofeng, et al.
Publicado: (2022)

Contemporary Trends in Malignant Peritoneal Mesothelioma: Incidence and Survival in the United States
por: Calthorpe, Lucia, et al.
Publicado: (2022)

The Biology of Malignant Mesothelioma and the Relevance of Preclinical Models
por: Blanquart, Christophe, et al.
Publicado: (2020)

Immune Microenvironment and Genetics in Malignant Pleural Mesothelioma
por: Wadowski, Benjamin, et al.
Publicado: (2021)

Malignant Peritoneal Mesothelioma Mimicking Ischemic Colitis
por: Mitsuka, Yuusuke, et al.
Publicado: (2010)

Malignant peritoneal mesothelioma. Is there a new treatment?
por: Rasul, Kakil Ibrahim, et al.
Publicado: (2009)

Malignant Peritoneal Mesothelioma Presenting as Mucinous Ascites
por: Field, Zachary, et al.
Publicado: (2018)

Malignant Peritoneal Mesothelioma Mimicking Recurrent Diverticulitis
por: Robalino Gonzaga, Ernesto S, et al.
Publicado: (2019)

Malignant Peritoneal Mesothelioma Without Asbestos Exposure
por: Abbas, Hafsa, et al.
Publicado: (2019)

Unusual radiologic presentations of malignant peritoneal mesothelioma
por: Sugarbaker, Paul Hendrick, et al.
Publicado: (2020)

Malignant Peritoneal Mesothelioma with Latent Tuberculosis Infection
por: Inoue, Naonori, et al.
Publicado: (2021)

Malignant peritoneal mesothelioma—a diagnostic challenge
por: Abdul Razzak, Saad, et al.
Publicado: (2022)

Malignant Peritoneal Mesothelioma: A Case Report
por: Sousa, Bárbara, et al.
Publicado: (2023)

Diffuse malignant peritoneal mesothelioma: A review
por: Sun, Luanbiao, et al.
Publicado: (2023)

Microenvironment-Dependent Phenotypic Changes in a SCID Mouse Model for Malignant Mesothelioma
por: Darai-Ramqvist, Eva, et al.
Publicado: (2013)

Bilateral Malignant Mesothelioma of Tunica Vaginalis A Case Report on Rare Presentation
por: Shaikh, Ashhad A., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_pubadqv9i3jle299ionif9r3eh